Actinium Pharmaceuticals, Inc. (ATNM)
Operating Income Growth
121.60%
TTM · Period ending:
ATNM Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported121.60%period ending
Latest reported121.60%period ending
ATNM TTM Operating Income YoY % (-30.53% → 121.60%)
Year-over-year change
High-resolution chart · PNG
ATNM operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 121.5969% | |
| 48.1063% | |
| 13.9455% | |
| 16.951% | |
| 5.2709% | |
| 1.5441% | |
| 18.8733% | |
| 14.9599% | |
| 3.326% | |
| -23.2183% | |
| -52.2402% | |
| -71.3101% | |
| -75.4967% | |
| -63.6937% | |
| -36.6127% | |
| -32.1614% | |
| -22.3872% | |
| -12.1094% | |
| -11.4813% | |
| -13.4013% | |
| -3.9968% | |
| -0.1248% | |
| -1.4613% | |
| 13.4848% | |
| 7.3483% | |
| 4.8268% | |
| 7.3759% | |
| -4.9843% | |
| -0.764% | |
| 8.9791% | |
| 11.4563% | |
| 20.5391% | |
| 19.933% | |
| 11.1441% | |
| -0.2347% | |
| -14.394% | |
| -28.7233% | |
| -24.7529% | |
| -8.1229% | |
| 6.881% | |
| 22.9847% | |
| 12.3698% | |
| -10.4533% | |
| -56.7049% | |
| -150.4204% | |
| -201.0107% | |
| -241.0346% | |
| -31.0736% | |
| 15.7195% | |
| 34.0029% | |
| 45.8577% | |
| -207.1993% | |
| -648.2831% | |
| -1,202.894% | |
| -122,240.4341% | |
| -26,926.6204% | |
| -8,536.5935% | |
| -4,462.0472% | |
| 61.8009% | |
| 41.0037% | |
| -3.232% | |
| -18.7968% | |
| -62.5772% | |
| -83.1327% | |
| -43.9683% | |
| 9.2657% | |
| 39.3429% | |
| 40.9137% | |
| 46.9884% | |
| 5.0972% | |
| -112.5764% | |
| -59.4285% | |
| -30.5301% |